Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

European Stock Futures Lower; Vaccine Optimism Wanes

Published 11/17/2020, 02:01 AM
Updated 11/17/2020, 02:03 AM
© Reuters.

By Peter Nurse 

Investing.com - European stock markets are seen opening lower Tuesday, handing back some of Monday’s sharp gains after optimism over the latest positive Covid-19 vaccine news wanes.

At 2:05 AM ET (0705 GMT), the DAX futures contract in Germany traded 0.4% lower, CAC 40 futures in France dropped 0.3% and the FTSE 100 futures contract in the U.K. fell 0.4%. 

Investor sentiment was given a boost Monday when Moderna (NASDAQ:MRNA) said its experimental Covid-19 vaccine was 94.5% effective in preventing infection, adding to Pfizer’s promising trial data last week.

This resulted in strong equity market gains, with the FTSE 100 and the CAC 40 both closing 1.7% higher and the DAX gaining 0.5%.

However, investors have started to reassess the situation amid worries over vaccine production and delivery, and given the ever-increasing number of coronavirus cases globally, particularly in the U.S..

The World Health Organization welcomed the vaccine news but said that "many questions" remained and there was no time for complacency, particularly as only very limited amounts of any vaccine will be available in the first half of 2021 for people other than priority health workers.

A number of European countries appear to have had some success in controlling the rate of growth of new cases, largely by shutting parts of  their economies down again, but the situation in the U.S., the world's largest economy, looks much more grim. 

The United States recorded more than one million new Covid-19 cases last week, with new infections rising in every state except for Hawaii, according to Reuters data, while deaths increased 12% in the week ended Nov. 15.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In corporate news, Dassault Systemes (PA:DAST) will be in focus Tuesday after the French technology and software company issued a new financial outlook on Tuesday, forecasting solid growth in its cash flow over the next few years.

Oil prices edged higher Monday, helped by the news of another promising vaccine trial and expectations that the world’s top producers will agree to a further extension of supply curbs.

OPEC+, a group which includes members of the Organization of the Petroleum Exporting Countries as well as Russia, is due to hold a ministerial committee meeting later Tuesday which could recommend changes to production quotas when all the ministers meet on Nov. 30 and Dec. 1.

Expectations are growing that the group will suggest a postponement of the planned January increase in oil output for at least three months to support prices as the pandemic continues to hit demand.

U.S. crude futures traded 0.2% higher at $41.40 a barrel, while the international benchmark Brent contract rose 0.6% to $44.08.

Elsewhere, gold futures traded flat at $1,887.80/oz, while EUR/USD traded 0.1% higher at 1.1858.



Latest comments

but but... I was told that with vaccines the stock market can not go down.
same headline of past week.
For just .3 and .4%😳🤣
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.